Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03947541
Other study ID # Pro00100497
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 14, 2019
Est. completion date December 30, 2021

Study information

Verified date October 2021
Source Duke University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study is being done to assess if the use of bracing helps improve quality of life of patients that are undergoing a spinal fusion for deformity. If the participant agrees to be in this trial they will be randomly assigned (like the flip of a coin) to receive either brace treatment or non-brace treatment. Regardless of what treatment group the participants are in, they will undergo surgery as planned. After surgery, patients in both groups will be treated per standard of care.


Recruitment information / eligibility

Status Completed
Enrollment 14
Est. completion date December 30, 2021
Est. primary completion date December 30, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - The principal investigator's new or returning patients - Adults 18 to 80 years of old - Undergoing a spinal fusion procedure of greater than or equal to 5 levels for the purpose of correcting idiopathic spinal deformity Exclusion Criteria: - Patients who are undergoing a spinal fusion for other reasons besides deformity - Patients who are unable to provide consent or fill out survey questionnaires - Patients who have brace-prohibitive body habitus - Patients who are unable to obtain standing AP and lateral 3-foot standing scoliosis x-rays

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Thoracolumbosacral (TLSO) brace
Patients will be required to wear the TLSO brace when out of bed, beginning on postoperative day 2 through 6 week follow-up period.
No Bracing
Participants will not wear a brace in the study.

Locations

Country Name City State
United States Duke University Medical Center Durham North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Duke University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Oswestry Disability Index (ODI) score Scores from 0 to 5, and the total is added and multiplied by 2. Therefore, the ODI ranges from 0 to 100. A higher score on the ODI indicates a more severe disability. Baseline, 3 months, 6 months, 12 months and 24 months
Secondary Changes in Scoliosis Research Society Outcomes Questionnaire (SRS-22 and SRS-30) Measures quality of life across 5 domains - Function (5 questions), Pain (5 questions) Self-Image (5 questions), Mental Health (5 questions), Satisfaction/Dissatisfaction (2 questions). The maximum score in each domain is 5 and minimum score is 1, with higher scores representing greater patient quality of life. Baseline, 3 months, 6 months, 12 months and 24 months
Secondary Change in Visual Analogue Scale (VAS) Scale from 0 to 10, 0 being no pain and 10 being worst pain imaginable. Baseline, 3 months, 6 months, 12 months and 24 months